Virus-mimetic polymeric micelles for targeted siRNA delivery

Biomaterials

Volumn 31, Issue 22, 2010, Pages 5886-5893

  Xiong, Xiao Bing ^a   Uludaĝ, Hasan ^a   Lavasanifar, Afsaneh ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Drug targeting; Multidrug resistance; P glycoprotein; Polymeric micelles; SiRNA delivery

Indexed keywords

DRUG-TARGETING; MULTIDRUG RESISTANCE; P-GLYCOPROTEIN; POLYMERIC MICELLE; SIRNA DELIVERY;

BIOMIMETICS; CYTOLOGY; ETHYLENE; GLYCOPROTEINS; MICELLES; NUCLEIC ACIDS; PEPTIDES; POLYETHYLENE OXIDES; POLYMERS; VIRUSES;

RNA;

CELL PENETRATING PEPTIDE; DOXORUBICIN; GLYCOPROTEIN P; MACROGOL; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 1; POLYCAPROLACTONE; SMALL INTERFERING RNA; SPERMINE; VITRONECTIN RECEPTOR;

ARTICLE; CELL ADHESION; CHEMICAL STRUCTURE; CONTROLLED STUDY; CYTOPLASM; CYTOTOXICITY; DOWN REGULATION; DRUG DELIVERY SYSTEM; ENDOSOME; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GENE SILENCING; MICELLE; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE; VIRUS ENTRY;

BIOMIMETIC MATERIALS; CELL LINE, TUMOR; GENE EXPRESSION; HUMANS; MICELLES; P-GLYCOPROTEIN; POLYMERS; RNA, SMALL INTERFERING; TRANSFECTION; VIRUSES;

EID: 77953048951     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2010.03.075     Document Type: Article

References (46)

1. Hammond S.M., Caudy A.A., Hannon G.J. Post-transcriptional gene silencing by double-stranded RNA. Nat Rev Genet 2001, 2:110-119.
2. de Fougerolles A., Vornlocher H.P., Maraganore J., Lieberman J. Interfering with disease: a progress report on siRNA-based therapeutics. Nat Rev Drug Discov 2007, 6:443-453.
3. Honma K., Iwao-Koizumi K., Takeshita F., Yamamoto Y., Yoshida T., Nishio K., et al. RPN2 gene confers docetaxel resistance in breast cancer. Nat Med 2008, 14:939-948.
4. Pirollo K.F., Chang E.H. Targeted delivery of small interfering RNA: approaching effective cancer therapies. Cancer Res 2008, 68:1247-1250.
5. Aagaard L., Rossi J.J. RNAi therapeutics: principles, prospects and challenges. Adv Drug Deliv Rev 2007, 59:75-86.
6. Whitehead K.A., Langer R., Anderson D.G. Knocking down barriers: advances in siRNA delivery. Nat Rev Drug Discov 2009, 8:129-138.
7. Juliano R., Alam M.R., Dixit V., Kang H. Mechanisms and strategies for effective delivery of antisense and siRNA oligonucleotides. Nucleic Acids Res 2008, 36:4158-4171.
8. Kawakami S., Hashida M. Targeted delivery systems of small interfering RNA by systemic administration. Drug Metab Pharmacokinet 2007, 22:142-151.
9. Sanguino A., Lopez-Berestein G., Sood A.K. Strategies for in vivo siRNA delivery in cancer. Mini Rev Med Chem 2008, 8:248-255.
10. Soutschek J., Akinc A., Bramlage B., Charisse K., Constien R., Donoghue M., et al. Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature 2004, 432:173-178.
11. Bartlett D.W., Su H., Hildebrandt I.J., Weber W.A., Davis M.E. Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging. Proc Natl Acad Sci U S A 2007, 104:15549-15554.
12. Gary D.J., Puri N., Won Y.Y. Polymer-based siRNA delivery: perspectives on the fundamental and phenomenological distinctions from polymer-based DNA delivery. J Control Release 2007, 121:64-73.
13. Kumar L.D., Clarke A.R. Gene manipulation through the use of small interfering RNA (siRNA): from in vitro to in vivo applications. Adv Drug Deliv Rev 2007, 59:87-100.
14. Schaffer D.V., Fidelman N.A., Dan N., Lauffenburger D.A. Vector unpacking as a potential barrier for receptor-mediated polyplex gene delivery. Biotechnol Bioeng 2000, 67:598-606.
15. Edelstein M.L., Abedi M.R., Wixon J. Gene therapy clinical trials worldwide to 2007-an update. J Gene Med 2007, 9:833-842.
16. Smaglik P. Merck blocks 'safer' gene therapy trials. Nature 2000, 403:817.
17. Aliabadi H.M., Brocks D.R., Lavasanifar A. Polymeric micelles for the solubilization and delivery of cyclosporine A: pharmacokinetics and biodistribution. Biomaterials 2005, 26:7251-7259.
18. de Fougerolles A.R. Delivery vehicles for small interfering RNA in vivo. Hum Gene Ther 2008, 19:125-132.
19. Jeong J.H., Kim S.W., Park T.G. Molecular design of functional polymers for gene therapy. Prog Polym Sci 2007, 32:1239-1274.
20. Xiong X.B., Uludag H., Lavasanifar A. Biodegradable amphiphilic poly(ethylene oxide)-block-polyesters with grafted polyamines as supramolecular nanocarriers for efficient siRNA delivery. Biomaterials 2009, 30:242-253.
21. Svoboda P. Off-targeting and other non-specific effects of RNAi experiments in mammalian cells. Curr Opin Mol Ther 2007, 9:248-257.
22. Leonessa F., Green D., Licht T., Wright A., Wingate-Legette K., Lippman J., et al. MDA435/LCC6 and MDA435/LCC6MDR1: ascites models of human breast cancer. Br J Cancer 1996, 73:154-161.
23. Wong H.L., Bendayan R., Rauth A.M., Xue H.Y., Babakhanian K., Wu X.Y. A mechanistic study of enhanced doxorubicin uptake and retention in multidrug resistant breast cancer cells using a polymer-lipid hybrid nanoparticle system. J Pharmacol Exp Ther 2006, 317:1372-1381.
24. Xiong X.B., Mahmud A., Uludag H., Lavasanifar A. Multifunctional polymeric micelles for enhanced intracellular delivery of doxorubicin to metastatic cancer cells. Pharm Res 2008, 25:2555-2566.
25. Xiong X.B., Mahmud A., Uludag H., Lavasanifar A. Conjugation of arginine-glycine-aspartic acid peptides to poly(ethylene oxide)-b-poly(epsilon-caprolactone) micelles for enhanced intracellular drug delivery to metastatic tumor cells. Biomacromolecules 2007, 8:874-884.
26. Itaka K., Kanayama N., Nishiyama N., Jang W.D., Yamasaki Y., Nakamura K., et al. Supramolecular nanocarrier of siRNA from PEG-based block catiomer carrying diamine side chain with distinctive pK(a) directed to enhance intracellular gene silencing. J Am Chem Soc 2004, 126:13612-13613.
27. Kim S.H., Jeong J.H., Cho K.C., Kim S.W., Park T.G. Target-specific gene silencing by siRNA plasmid DNA complexed with folate-modified poly(ethylenimine). J Control Release 2005, 104:223-232.
28. Lee S.H., Kim S.H., Park T.G. Anticancer effect by intratumoral and intravenous administration of VEGF siRNA polyelectrolyte complex micelles. J Biotechnol 2007, 131:S48-S49.
29. Nishiyama N., Kataoka K. Current state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene delivery. Pharmacol Ther 2006, 112:630-648.
30. Oba M., Aoyagi K., Miyata K., Matsumoto Y., Itaka K., Nishiyama N., et al. Polyplex micelles with cyclic RGD peptide ligands and disulfide cross-links directing to the enhanced transfection via controlled intracellular trafficking. Mol Pharmacol 2008, 5:1080-1092.
31. Oba M., Fukushima S., Kanayama N., Aoyagi K., Nishiyama N., Koyama H., et al. Cyclic RGD peptide-conjugated polyplex micelles as a targetable gene delivery system directed to cells possessing alphavbeta3 and alphavbeta5 integrins. Bioconjug Chem 2007, 18:1415-1423.
32. Suk J.S., Suh J., Choy K., Lai S.K., Fu J., Hanes J. Gene delivery to differentiated neurotypic cells with RGD and HIV Tat peptide functionalized polymeric nanoparticles. Biomaterials 2006, 27:5143-5150.
33. Medina-Kauwe L.K. Endocytosis of adenovirus and adenovirus capsid proteins. Adv Drug Deliv Rev 2003, 55:1485-1496.
34. Bayer P., Kraft M., Ejchart A., Westendorp M., Frank R., Rosch P. Structural studies of HIV-1 Tat protein. J Mol Biol 1995, 247:529-535.
35. Sawant R.M., Hurley J.P., Salmaso S., Kale A., Tolcheva E., Levchenko T.S., et al. "SMART" drug delivery systems: double-targeted pH-responsive pharmaceutical nanocarriers. Bioconjug Chem 2006, 17:943-949.
36. Renigunta A., Krasteva G., Konig P., Rose F., Klepetko W., Grimminger F., et al. DNA transfer into human lung cells is improved with Tat-RGD peptide by caveoli-mediated endocytosis. Bioconjug Chem 2006, 17:327-334.
37. Gao Z., Fain H.D., Rapoport N. Ultrasound-enhanced tumor targeting of polymeric micellar drug carriers. Mol Pharmacol 2004, 1:317-330.
38. Liu T.B., Nace V.M., Chu B. Self-assembly of mixed amphiphilic triblock copolymers in aqueous solution. Langmuir 1999, 15:3109-3117.
39. Vakil R., Kwon G.S. Poly(ethylene glycol)-b-poly(epsilon-caprolactone) and PEG-phospholipid form stable mixed micelles in aqueous media. Langmuir 2006, 22:9723-9729.
40. Smith C.K., Liu G.J. Determination of the rate constant for chain insertion into poly(methyl methacrylate)-block-poly(methacrylic acid) micelles by a fluorescence method. Macromolecules 1996 Mar 11, 29(6):2060-2067.
41. Vangeyte P., Leyh B., Heinrich M., Grandjean J., Bourgaux C., Jerome R. Self-assembly of poly(ethylene oxide)-b-poly(epsilon-caprolactone) copolymers in aqueous solution. Langmuir 2004, 20:8442-8451.
42. Wang X.L., Nguyen T., Gillespie D., Jensen R., Lu Z.R. A multifunctional and reversibly polymerizable carrier for efficient siRNA delivery. Biomaterials 2008, 29:15-22.
43. Ferrer-Miralles N., Vazquez E., Villaverde A. Membrane-active peptides for non-viral gene therapy: making the safest easier. Trends Biotechnol 2008, 26:267-275.
44. Nativo P., Prior I.A., Brust M. Uptake and intracellular fate of surface-modified gold nanoparticles. ACS Nano 2008, 2:1639-1644.
45. Shayakhmetov D.M., Eberly A.M., Li Z.Y., Lieber A. Deletion of penton RGD motifs affects the efficiency of both the internalization and the endosome escape of viral particles containing adenovirus serotype 5 or 35 fiber knobs. J Virol 2005, 79:1053-1061.
46. Maraldi N.M., Zini N., Santi S., Scotlandi K., Serra M., Baldini N. P-glycoprotein subcellular localization and cell morphotype in MDR1 gene-transfected human osteosarcoma cells. Biol Cell 1999, 91:17-28.